Balance Sheet
Cash Flow Statement
AcquisitionsAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Depreciation and Depletion (2022 - 2023)

Historic Depreciation and Depletion for Cellebrite DI (CLBT) over the last 2 years, with Q4 2023 value amounting to $1.7 million.

  • Cellebrite DI's Depreciation and Depletion rose 344.01% to $1.7 million in Q4 2023 from the same period last year, while for Dec 2023 it was $6.6 million, marking a year-over-year change of. This contributed to the annual value of $7.3 million for FY2024, which is 891.36% up from last year.
  • Latest data reveals that Cellebrite DI reported Depreciation and Depletion of $1.7 million as of Q4 2023, which was up 344.01% from $1.5 million recorded in Q3 2023.
  • Over the past 5 years, Cellebrite DI's Depreciation and Depletion peaked at $1.7 million during Q4 2023, and registered a low of $1.5 million during Q3 2023.